Ki-67 mRNA as a predictor for response to neoadjuvant chemotherapy in primary breast cancer

被引：0
|
作者：
Marme, F.
Schneeweiss, A.
Aigner, J.
Eidt, S.
Altevogt, P.
Sinn, P.
Wirtz, R. M.
机构：
[1] Univ Heidelberg Hosp, Natl Ctr Tumor Dis, Heidelberg, Germany
[2] St Elizabeth Hosp, Inst Pathol, Cologne, Germany
[3] German Canc Res Ctr, Heidelberg, Germany
[4] Heidelberg Univ, D-69115 Heidelberg, Germany
[5] STRATIFYER MolecularPathol GmbH, Cologne, Germany
来源：
CANCER RESEARCH | 2012年 / 72卷
关键词：
D O I：
10.1158/0008-5472.SABCS12-P3-06-08
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P3-06-08
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Ki-67 as a controversial predictive and prognostic marker in breast cancer patients treated with neoadjuvant chemotherapy
    Acs, Balazs
    Zambo, Veronika
    Vizkeleti, Laura
    Szazs, A. Marcell
    Madaras, Lilla
    Szentmartoni, Gyongyver
    Tokes, Timea
    Molnar, Bela A.
    Molnar, Istvan Artur
    Vari-Kakas, Stefan
    Kulka, Janina
    Tokes, Anna-Maria
    [J]. DIAGNOSTIC PATHOLOGY, 2017, 12 : 1 - 12
  • [22] Ki-67 CAN BE USED AS A PREDICTIVE FACTOR FOR THE EFFECTIVENESS OF NEOADJUVANT CHEMOTHERAPY IN BREAST CANCER PATIENTS
    Kozar, N.
    Sikosek, N. Cas
    Arko, D.
    Ravnik, M.
    Takac, I.
    [J]. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2017, 27 : 115 - 115
  • [23] Ki-67 as a controversial predictive and prognostic marker in breast cancer patients treated with neoadjuvant chemotherapy
    Balázs Ács
    Veronika Zámbó
    Laura Vízkeleti
    A. Marcell Szász
    Lilla Madaras
    Gyöngyvér Szentmártoni
    Tímea Tőkés
    Béla Á. Molnár
    István Artúr Molnár
    Stefan Vári-Kakas
    Janina Kulka
    Anna-Mária Tőkés
    [J]. Diagnostic Pathology, 12
  • [24] KI-67 CAN BE USED AS A PREDICTIVE FACTOR FOR THE EFFECTIVENESS OF NEOADJUVANT CHEMOTHERAPY IN BREAST CANCER PATIENTS
    Kozar, N.
    Sikosek, N. Cas
    Arko, D.
    Ravnik, M.
    Takac, I.
    [J]. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2017, 27 : 635 - 635
  • [25] Pathological complete response in early breast cancer patients undergoing neoadjuvant chemotherapy: Focus on Ki-67 and molecular subtypes
    Rapoport, B. L.
    Barnard-Tidy, J.
    Van Eeden, R. I.
    Smit, T.
    Nayler, S.
    Benn, C.
    [J]. ANNALS OF ONCOLOGY, 2019, 30 : 37 - 37
  • [26] Prognostic function of Ki-67 for pathological complete response rate of neoadjuvant chemotherapy in triple-negative breast cancer
    Zhang, Guojing
    Xie, Wanqing
    Liu, Zhaozhe
    Lin, Chao
    Piao, Ying
    Xu, Long
    Guo, Fang
    Xie, Xiaodong
    [J]. TUMORI JOURNAL, 2014, 100 (02): : 136 - 142
  • [27] Ki-67 as a prognostic marker according to breast cancer subtype and a predictor of recurrence time in primary breast cancer
    Nishimura, Reiki
    Osako, Tomofumi
    Okumura, Yasuhiro
    Hayashi, Mitsuhiro
    Toyozumi, Yasuo
    Arima, Nobuyuki
    [J]. EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2010, 1 (05) : 747 - 754
  • [28] Ki-67 as Predictive Biomarker for Systemic Chemotherapy in Breast Cancer
    Bhamre, R.
    Patil, A.
    Singhai, R.
    [J]. EUROPEAN JOURNAL OF CANCER, 2012, 48 : S132 - S132
  • [29] Ki-67 Expression by Immunohistochemistry and Quantitative Real-Time Polymerase Chain Reaction as Predictor of Clinical Response to Neoadjuvant Chemotherapy in Locally Advanced Breast Cancer
    Prihantono, Prihantono
    Hatta, Mochammad
    Binekada, Christian
    Sampepajung, Daniel
    Haryasena, Haryasena
    Nelwan, Berti
    Islam, Andi Asadul
    Usman, Andi Nilawati
    [J]. JOURNAL OF ONCOLOGY, 2017, 2017
  • [30] Changes in PgR and Ki-67 in residual tumour and outcome of breast cancer patients treated with neoadjuvant chemotherapy
    Montagna, E.
    Bagnardi, V.
    Viale, G.
    Rotmensz, N.
    Sporchia, A.
    Cancello, G.
    Balduzzi, A.
    Galimberti, V.
    Veronesi, P.
    Luini, A.
    Mastropasqua, M. G.
    Casadio, C.
    Sangalli, C.
    Goldhirsch, A.
    Colleoni, M.
    [J]. ANNALS OF ONCOLOGY, 2015, 26 (02) : 307 - 313
12345